Valuation: OrganiGram

Market Cap 192M 137M 123M 112M 102M 12.99B 196M 1.34B 541M 6.86B 515M 504M 21.66B P/E 2026 *
1.69x
P/E 2027 * 17x
Enterprise Value 192M 137M 123M 112M 102M 12.99B 196M 1.34B 541M 6.86B 515M 504M 21.66B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Operating Officer - 18/08/2026
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 137M
+0.60%-2.39%+13.40%+26.62% 113B
+0.46%+3.69%+1.09%+102.12% 97.71B
+3.69%-4.38%+98.17%+819.12% 54.62B
+4.02%+1.17%-6.04%+82.74% 30.65B
+0.57%+7.90%+38.59%+69.98% 28.87B
+0.23%+3.52%+40.41%+87.52% 27.59B
+1.73%+1.93%+32.63%+386.36% 21.4B
-1.28%-5.43%-21.72%-16.73% 19.74B
-1.15%-1.02%-7.07%+29.55% 17.04B
Average +0.50%-0.29%+21.05%+176.36% 45.65B
Weighted average by Cap. +1.09%-1.27%+22.34%+178.04%

Financials

2026 *2027 *
Net sales 350M 250M 223M 205M 187M 23.7B 357M 2.45B 987M 12.51B 939M 919M 39.51B 458M 328M 293M 269M 244M 31.04B 467M 3.21B 1.29B 16.38B 1.23B 1.2B 51.74B
Net income 128M 91.83M 81.98M 75.23M 68.44M 8.69B 131M 899M 362M 4.59B 345M 337M 14.49B 8.1M 5.8M 5.18M 4.75M 4.32M 549M 8.26M 56.73M 22.87M 290M 21.76M 21.29M 915M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OrganiGram